2022/3 Warwick Evidence Projects
2022/3 Warwick Evidence Projects
This year we have been and are working on the following projects:
- Ataluren for duchenne muscular dystrophy (nonsense mutation) (review of HST3) [ID1642]Link opens in a new windowLink opens in a new window
- Diroximel fumarate for treating relapsing‐remitting multiple sclerosis (ID1673)Link opens in a new windowLink opens in a new window
- Dostarlimab for recurrent, advanced, high microsatellite instability, mismatch repair deficiency, treated endometrial cancer (ID3802)Link opens in a new windowLink opens in a new window
- Early Value Assessment: Artificial Intelligence for analysing chest x-ray images to diagnose lung cancer [DAP68]Link opens in a new windowLink opens in a new window
- Faricimab for treating wet age-related macular degeneration [ID3898]Link opens in a new windowLink opens in a new window
- Hybrid closed loop systems for managing blood glucose levels in type 1 diabetesLink opens in a new windowLink opens in a new window
- Ixazomib citrate with lenalidomide and dexamethasone, post prior therapy for relapsed, refractory multiple myeloma (CDF review of TA505)Link opens in a new windowLink opens in a new window (ID1635)
- Lisocabtagene maraleucel for treating large B‐cell lymphoma after at least 2 therapies (part 1) ID1444Link opens in a new windowLink opens in a new window
- Lisocabtagene maraleucel for treating large B‐cell lymphoma after at least 2 therapies (part 2) (ID1444)Link opens in a new windowLink opens in a new window
- Mosunetuzumab for treating relapsed or refractory follicular lymphoma [ID3931]Link opens in a new windowLink opens in a new window
- Olaparib for previously treated, hormone‐relapsed metastatic prostate cancer (ID1640)Link opens in a new windowLink opens in a new window
- Update of DG21 Integrated sensor‐augmented pump therapy systems for managing blood glucose levels in type 1 diabetesLink opens in a new windowLink opens in a new window
- Sacituzumab govitecan for treating unresectable triple-negative advanced breast cancer after 2 or more therapies [ID3942]Link opens in a new windowLink opens in a new window
- Software with artificial intelligence derived algorithms for automated detection and analysis of lung nodules from CT scan images [DAP60] Link opens in a new windowLink opens in a new window
- Venetoclax with obinutuzumab for untreated chroniclymphocytic leukaemia [ID1402]Link opens in a new window